Two-stage treatment of chronic staphylococcal orthopaedic implant- related infections using vancomycin impregnated PMMA spacer and rifampin containing antibiotic protocol

Bulletin: Hospital for Joint Diseases

Volumn 58, Issue 2, 1999, Pages 79-85

  Isiklar, Z U ^a   Demirors H ^b   Akpinar, S ^b   Tandogan, R N ^b   Alparslan, M ^c  

^a Ortopedi ve Travmatoloji Tedavi M   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Orthopaedic implant infection; Rifampin; Two stage exchange

Indexed keywords

C REACTIVE PROTEIN; CIPROFLOXACIN; METICILLIN; POLY(METHYL METHACRYLATE); RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ARTHROPLASTY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEMUR NECK FRACTURE; GRAFT INFECTION; HIP ARTHROPLASTY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; PROSTHESIS FAILURE; PSEUDARTHROSIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 0032828263     PISSN: 00185647     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Brause BD: Infected orthopaedic prosthesis. In: Bisno AL. Waldvogel FA (eds): Infection Associated with Indwelling Medical Devices. Washington, DC: American Society of Microbiology, 1989, pp. 111-117.
2. Praemer A, Fumer S, Rice DP: Musculoskeletal Conditions in the United States. American Academy of Orthopedic Surgeons, 1992, pp. 127-141.
3. Needham CA, Stempsey W: Incidence, adherence and antibiotic resistance of coagulase negative staphylococcus species causing human disease. Diag Microbiol Infect Dis 2:293-299, 1984.
4. Nichols WW, Evans MJ, Slack MPE, et al: The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J Gen Microbiol 135:1291-1303, 1989.
5. Brown MRW, Allison DG, Gilbert P: Resistance of bacterial biofilms to antibiotics: A growth-rate related effect? J Antimicrob Chemother 22:777-780, 1988.
6. Darouiche RO, Dhir A, Miller AJ, et al: Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 170:720-723, 1994.
7. Isiklar ZU, Landon GC, Daruiche R, et al: Penetration of vancomycin into biofilm: An in vivo implant infection model. ORS Transactions 18(2):458, 1993.
8. Farber BF, Kaplan MH, Glogston AG: Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of giycopeptide antibiotics. J Infect Dis 161:37-40, 1990.
9. Darouiche RO, Raad II, Bodey GP, et al: Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter related bacteremia: Potential role of combination of minocycline and rifampin Int J Antimicrob Agents 6:31-36, 1995.
10. Drancourt M, Stein A, Argenson JN, et al: Oral rifampin plus ofloxacin for treatment of Staphylococcus infected orthopaedic implants. Antimicrob Agents Chemother 37:1214-1218, 1993.
11. Richards GK, Gagnon RF, Prentis J: Comparative rates of antibiotic action against Staphylococcus epidermidis biofilms. ASAIO Trans 37(3):160-162, 1991.
12. Dunne WM, Mason EO Jr, Kaplan SL: Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 37:2522-2526, 1993.
13. Obst G, Gagnon RF, Prentis J, et al: Rifampin activity against Staphylococcus epidermidis biofilms. Trans Am Soc Artif Intern Organs 34:882-784, 1988.
14. Obst G, Gagnon RF, Harris A, et al: The activity of rifampin and analogs against Staphylococcus epidermidis biofilms in CAPD environment model. Am J Nephrol 9:414-420, 1989.
15. Gagnon, RF, Richards GK, Wiesenfeld L: Staphylacoccus epidermidis biofilms Unexpected outcome of double and triple antibiotic combinations with rifampin. ASAID Trans 37(3):158-160, 1991.
16. Isiklar ZU, Darouiche RO, Landon GC, et al: Efficacy of antibiotics alone for orthopedic device relate infections. Clin Orthop 332:184-189, 1996.
17. Widmer AF, Gaechter A, Ochsner PE, et al: Antimicrobial treatment of orthopaedic implant-related infections With rifampin combinations. Clin Infect Dis 14:1251-1253, 1992.
18. Crockarell JR, Hanssen AD, Osmon DR, et al: Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg 80A:1306-1313, 1998.
19. Ure KJ, Amstutz HC, Nasser S, et al: Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten year follow-up. J Bone Joint Surg 80A:961-968, 1998.
20. Salvati EA, Chekofsky KM, Brause BD, et al: Reimplantation in infection: A 12 year experience. Clin Orthop 170:62-75, 1982.
21. McDonald DJ, Fitzgerald RH Jr, Ilstrup DM: Two-stage reconstruction of total hip arthroplasty because of infection. J Bone Joint Surg 71A:828-834, 1989.
22. Lieberman JR, Callaway GH, Salvati EA, et al: Treatment of infected total hip arthroplasty with two-stage reimplantation protocol. Clin Orthop 301:205-212, 1994.
23. Nestor BJ, Hanssen AD, Ferrer-Gonzales R, et al: The use of porous prosthesis in delayed reconstruction of total hip replacements that have failed because of infection. J Bone Joint Surg 76A:349-359, 1994.
24. Tsukayama DT, Estrada R, Gustilo RB: Infection after total hip arthroplasty: A study of the treatment of one hundred and six infections. J Bone Joint Surg 78A:512-523, 1996.
25. Wang JW, Chen CE: Reimplantation of the infected hip arthroplastics using bone allografts. Clin Orthop 335:202-210, 1997.
26. Ballard WT, Lowry DA, Brand RA: Resection arthroplasty of the hip. J Arthroplasty 10(6):772-779, 1995.
27. Kantor GS, Osterkamp JA, Dorr LD, et al: Resection arthroplasty following infected total hip replacement arthroplasty. J Arthroplasty 1(2):83-89, 1986.
28. Kraay MJ, Goldberg VM, Figgie HE: Use of an antibiotic impregnated PMMA intramedullary spacer for complicated revision total hip arthroplasty. J Arthroplasty 7(Suppl):397-402, 1992.
29. Ozaki T, Yoshitaka T, Kunisada T, et al: Vancomycin-impregnated PMMA beads for methicillin-resistant Staphylococcus aureus (MRSA) infection: Report of two cases. J Orthop Sci 3(3):163-168, 1998.
30. Chofi M, Langais F, Fourastier J, et al: Pharmacokinetics, uses, and limitations of vancomycin loaded bone cement. Int Orthop 22(3):171-177, 1998.
31. Deshmukh RG, Thevarajyan K, Kok CS, et al: An intra-medullary cement spacer in total hip arthroplasty. J Arthroplasty 13(2):197-199, 1998.
32. Masri BA, Duncan CP, Beauchhamp CP: Long term evaluation of antibiotics from bone cement: An in vivo study using the prosthesis of antibiotic-loaded acrylic cement (Prostalac) system. J Arthroplasty 13(3):331-338, 1998.
33. Migaud H, Chantelot C, Besson A, et al: Temporary antibiotic-loaded cemented prosthesis for two-stage septic hip arthroplasty. Rev Chir Orthop Reparatice Appar Mot 84(5):466-468, 1997.
34. Feldman DS, Lonner JH, Desai P, et al: The role of intraoperative frozen sections in revision total hip arthroplasty. J Bone Joint Surg 77A: 1807-1813, 1995.